1800 244 735

Helpline (02) 9874 9777

Coming Soon: EuroBuzz 2012

Stand by for EuroBuzz – hot-off-the-press Huntington’s disease research news from the European HD Network Meeting in Stockholm, brought to you by HDBuzz.

EHDN 2012

The European Huntington’s Disease Network (EHDN) is a Europe-wide collaboration of HD professionals, researchers and people affected by HD. EHDN exists to encourage sharing information and ideas about HD, studies and possible treatments, throughout Europe and beyond

EHDN 2012, in Stockholm, Sweden, is the 7th meeting of the whole Network. It’s one of the largest gatherings of HD researchers in the world, and this year’s meeting promises to be the biggest and most exciting EHDN conference yet. Nearly a thousand delegates are expected to attend, and over 300 posters and dozens of fascinating and innovative platform talks will be presented – all dedicated to understanding and developing treatments for Huntington’s disease.

The meeting kicks off this Friday, 14th September, and runs until Sunday 16th.

EuroBuzz!

HDBuzz reporters Dr Ed Wild and Dr Jeff Carroll will be bringing you live updates from the meeting, starting at 9am Swedish time (8am BST / 3am EDT) on Friday 14th September. Follow @hdbuzzfeed on Twitter to get the live feed. We’re calling our coverage EuroBuzz 2012.

Each day, all our updates will be brought together at hdbuzz.net as a single news story.

But wait – there’s more

At the end of each day’s science presentations on Friday 14th and Saturday 15th September, Ed and Jeff will take to the stage to interview the top scientists who’ve presented their research at the meeting. We’ll be getting the lowdown directly, and helping our guests to steer clear of jargon and science-speak.

Video of these live sessions will be available shortly afterwards, at hdbuzz.net.

Get involved

We want you to get involved, by sending us questions to ask our expert guests.

Just follow @hdbuzzfeed on Twitter and send us your question as a tweet.

Our confirmed guests so far are:

    n

  • Dr Ray Truant: the huntingtin protein and how it causes damage

  • n

  • Dr Mike Orth: using advanced scanning techniques to detect brain changes before disease onset

  • n

  • Dr Bev Davidson – gene silencing treatments for Huntington’s disease

  • n

  • Dr Lisa Ellerby – stem cells and how they can help fight HD

  • n

Plus we’ll be covering the controversial topic of diagnosing ‘disease onset’ in HD and phosphodiesterase (PDE) inhibitors, a new and exciting possible approach to treating HD symptoms.

You can also see the program for the whole meeting at the EHDN website, euro-hd.net.

We’re looking forward to three days of great science, and we hope you’ll join us for EuroBuzz 2012!

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest Research Articles

Updates from the EHDN Meeting 2021

Published date: 28 October, 2021

Last month, the Huntington’s disease (HD) research community, patients and other stakeholders met online at the European Huntington’s disease network (EHDN) conference. Despite the ongoing global pandemic, there is a tremendous amount of work underway in labs and clinics around the world as researchers continue to better understand HD and how we might best treat ... Read more

Real talk: Q&A with Roche about GENERATION-HD1

Published date: 28 September, 2021

At the end of day 1 of the European Huntington’s Disease Network (EHDN) conference, the HDBuzz team (minus one) sat down for a zoom chat with the team at Roche to have a frank, candid discussion about the recent halting of GENERATION-HD1, the Phase 3 clinical trial that was testing the ability of the antisense ... Read more

Another tool in the box: Creation of a molecular “dimmer switch” advances gene editing

Published date: 30 August, 2021

A team of scientists recently created an innovative genetic system where a drug taken by mouth could be used to control the action of a gene editor, like those used in CRISPR systems. This has useful applications for research studies in cells and animals, and perhaps most importantly, could lead to improvements in the safety ... Read more

Unpacking recent gene therapy press

Published date: 16 August, 2021

A recent announcement from Voyager Therapeutics outlined a shift in the company’s strategy towards an exciting new technology for gene therapy delivery. Unfortunately this also means that in the short term, they have dropped previous plans to test an HD gene therapy in people with HD. While this news is disappointing, the decision to embrace ... Read more

Does blood hold the key to testing treatments earlier in HD patients?

Published date: 4 August, 2021

Researchers at Johns Hopkins led by Wenzhen Duan have developed a non-invasive way to track progression of Huntington’s disease (HD) which could be used before patients even start showing symptoms. Using a type of brain scan called an MRI, the researchers have shown that in mouse models of HD they can accurately measure the amount ... Read more

A first for CRISPR gene editing could have wider applications for human disease

Published date: 21 July, 2021

A recent clinical trial successfully tested the safety of CRISPR gene editing to reduce the amount of a toxic protein in patients with Familial Transthyretic (TTR) Amyloidosis. Although this study is unrelated to Huntington’s disease, it’s a first for gene editing, and the results could have implications for HD and other brain disorders. CRISPR-Cas9 Clustered ... Read more